Investor and operating executive focused on growth-stage tech and consumer businesses. Amber Baker combines strategic investing with hands-on operational experience across scaling product, go-to-market and finance functions; has led corporate development and portfolio operational roles and frequently advises CEOs on growth execution and capital formation. Prior experience spans venture-backed startups and corporate strategy. Known for sourcing cross-border deals, structuring minority growth investments and driving revenue-led scale for late-seed to Series C opportunities.
Investor and operating executive focused on growth-stage tech and consumer businesses. Amber Baker combines strategic investing with hands-on operational experience across scaling product, go-to-market and finance functions; has led corporate development and portfolio operational roles and frequently advises CEOs on growth execution and capital formation. Prior experience spans venture-backed startups and corporate strategy. Known for sourcing cross-border deals, structuring minority growth investments and driving revenue-led scale for late-seed to Series C opportunities.
Focuses on growth-stage tech and consumer companies, deploying minority growth capital alongside hands-on operational support to scale product, go-to-market and finance functions. Prefers late-seed to Series C opportunities with clear revenue traction and unit-economics improvement potential, using a revenue-led underwriting lens and founder-aligned deal structures. Emphasizes cross-border sourcing, pragmatic cap‑table construction, 3–7 year value realization horizons, active portfolio involvement to drive customer acquisition, unit margin expansion and disciplined follow-on allocation.
Focuses on growth-stage tech and consumer companies, deploying minority growth capital alongside hands-on operational support to scale product, go-to-market and finance functions. Prefers late-seed to Series C opportunities with clear revenue traction and unit-economics improvement potential, using a revenue-led underwriting lens and founder-aligned deal structures. Emphasizes cross-border sourcing, pragmatic cap‑table construction, 3–7 year value realization horizons, active portfolio involvement to drive customer acquisition, unit margin expansion and disciplined follow-on allocation.
| Trades 879 | Longs Won 651/879 74% | Profit Factor 3.19 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $409,607.29 |
| Average Win $62,949.89 | Best Trade (Oct 16) $7.06M | Sharpe Ratio -9.24 |
| Average Loss -$56,275.54 | Worst Trade (Oct 14) -$8.77M | Z-Score 12.37 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 3w 6d | Expectancy $32,024.53 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.63% |
| Consecutive Losing Trades | 2,247 | 2,022 | 1,798 | 1,573 | 1,348 | 1,124 | 899 | 674 | 449 | 225 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 11,113 | $2.17M | $3.8M | - | $1.63M | 75.04% | -0.28% |
ABBV AbbVie Inc. | 2,279 | $366,209.04 | $645,868.58 | - | $279,659.54 | 76.37% | -0.028% |
ACWI iShares MSCI ACWI ETF | 1,645 | $232,751 | $261,933.35 | - | $29,182.35 | 12.54% | +0.302% |
ADT ADT Inc. | 25,382 | $210,711.14 | $174,120.52 | - | -$36,590.62 | -17.37% | +3.939% |
AIZ Assurant Inc. | 1,096 | $232,473.73 | $308,929.52 | - | $76,455.79 | 32.89% | +2.005% |
ALL Allstate Corporation | 1,448 | $299,505.19 | $346,940.81 | - | $47,435.62 | 15.84% | +1.452% |
ALSN Allison Transmission Holdings Inc. | 2,055 | $140,461.14 | $229,749 | - | $89,287.86 | 63.57% | -0.666% |
AMZN Amazon.com Inc | 25,367 | $4.01M | $6.46M | - | $2.45M | 61.17% | +0.268% |
AVGO Broadcom Inc. | 3,251 | $813,360.59 | $1.12M | - | $306,056.21 | 37.63% | -0.555% |
AXP American Express Company | 890 | $243,867.56 | $279,344.3 | - | $35,476.74 | 14.55% | +2.254% |
BAC Bank of America Corporation | 4,911 | $270,105 | $253,898.7 | - | -$16,206.3 | -6% | +0.603% |
BMY Bristol-Myers Squibb Company | 4,645 | $250,551 | $281,347.65 | - | $30,796.65 | 12.29% | +2.176% |
BNDX Vanguard Total International Bond ETF | 4,504 | $217,633 | $212,633.84 | - | -$4,999.16 | -2.3% | +0.34% |
BRK-B Berkshire Hathaway Inc. | 952 | $413,744.9 | $503,788.88 | - | $90,043.98 | 21.76% | +0.668% |
BWA BorgWarner Inc. | 5,327 | $240,035 | $312,535.09 | - | $72,500.09 | 30.2% | +0.291% |
BYD Boyd Gaming Corporation | 2,632 | $224,352 | $188,161.68 | - | -$36,190.32 | -16.13% | +0.733% |
CAH Cardinal Health Inc. | 1,778 | $184,555.95 | $453,390 | - | $268,834.05 | 145.67% | +0.508% |
CALM Cal-Maine Foods Inc. | 3,115 | $319,047.97 | $198,082.85 | - | -$120,965.12 | -37.91% | +0.633% |
CCK Crown Holdings Inc. | 2,350 | $241,980 | $268,452.25 | - | $26,472.25 | 10.94% | +0.488% |
CINF Cincinnati Financial Corporation | 1,251 | $204,313 | $209,192.22 | - | $4,879.22 | 2.39% | +0.33% |